When will they stop utilizing abysmal blood serology testing for Lyme research?
The authors state to retest despite the fact patients can continually be seronegative. I’ve heard experienced practitioners admit their sickest patients NEVER test positive. It’s still a head-scratcher why 2-tiered serology is the gold standard for diagnosis when it was only meant for surveillance purposes. Lyme was and will forever be a clinical diagnosis.
A much better indicator of infection is the Horowitz MSIDS questionnaire: https://madisonarealymesupportgroup.com/2017/09/05/empirical-validation-of-the-horowitz-questionnaire-for-suspected-lyme-disease/
Questionnaire here: https://madisonarealymesupportgroup.files.wordpress.com/2016/01/symptomlist.pdf
This study of pediatric patients shows what every single other study using two-tier testing shows: results cannot rule out Lyme borreliosis.
What a waste of time and money.
“These serologic tests cannot distinguish active infection, past infection, or reinfection.”
In plain English, these tests don’t show squat.